Although future experiments will have to determine the precise mechanisms of how a scaffold protein could affect the transcription of a set of genes, our study supports the idea that Shank3 downregulation affects both intrinsic excitability and synaptic properties, which may ultimately account for the symptom heterogeneity of PMS patients. The gene discussed is SHANK3; the disease is premenstrual tension.